Copy

Having trouble reading this email? View it in your browser

HHS releases new buprenorphine practice guidelines, expanding access to treatment for opioid use disorder

In an effort to get evidenced-based treatment to more Americans with opioid use disorder, the U.S. Department of Health and Human Services (HHS) is releasing new buprenorphine practice guidelines that among other things, remove a longtime requirement tied to training, which some practitioners have cited as a barrier to treating more people.
Signed by HHS Secretary Xavier Becerra, the Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder exempt eligible physicians, physician assistants, nurse practitioners, clinical nurse specialists, certified registered nurse anesthetists, and certified nurse midwives from federal certification requirements related to training, counseling, and other ancillary services that are part of the process for obtaining a waiver to treat up to 30 patients with buprenorphine.
Read More

Substance Abuse & Mental Health Services Administration 

5600 Fishers Lane Rockville, MD 20857 USA

1-877-SAMHSA-7 (1-877-726-4727) | www.samhsa.gov | Privacy

Subscribe. Forward to a friend.

This email was delivered to ptobias@ncsc.org. You are receiving this email because you opted in via our website.

Mobile Apps | Publications | UnsubscribeUpdate My Profile | Contact Us

Copyright © 2021. All rights reserved.